Blackstone is exploring options for HealthEdge Software, including the sale of a stake that could value the healthcare software company at about US$3 billion, people with knowledge of the matter said.
Blackstone is working with advisers on the possible sale of a 50 per cent stake in HealthEdge, which sells software to health insurers, the people said.
It's keen to bring in another financial investor to help it grow the business, one of the people said, asking not to not be identified discussing confidential information.
HealthEdge helps health insurers modernise their systems with software for plan design, enrolment and claims adjudication. It is projecting revenue of US$400 million next year and earnings of $60 million, one of the people said. Blackstone bought a majority stake in the Burlington, Massachusetts-based company in 2020.
Deliberations are in the early stages and there's no certainty they'll result in a stake sale, according to the people.
A representative for Blackstone declined to comment, while a spokesperson for HealthEdge didn't immediately respond to a request for comment. BLOOMBERG